Trials / Sponsors / Bial R&D Investments, S.A.
Bial R&D Investments, S.A.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in GBA-PD Parkinson's Disease | Phase 2 | 2023-03-31 |
| Completed | Mass Balance Recovery and Metabolite Identification of Carbon-14 BIA 28-6156 Parkinson Disease | Phase 1 | 2021-08-28 |
| Available | Compassionate Use for BIA 28-6156 in Patients With Parkinson's Disease (PD) Who Have a Pathogenic Variant in t Parkinson Disease | — | — |